Little association of lipid parameters and large sensory nerve fiber function in diabetes mellitus

Journal of Diabetes and its Complications

Volumn 10, Issue 1, 1996, Pages 54-59

  Maser, Raelene E ^a,b   Usher, David C ^a   DeCherney, G Stephen ^b  

^a UNIVERSITY OF DELAWARE   (United States)

^b MEDICAL CENTER OF DELAWARE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH DENSITY LIPOPROTEIN; LIPID; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

AGE; ARTICLE; BLOOD PRESSURE REGULATION; BODY HEIGHT; CHOLESTEROL BLOOD LEVEL; DIABETES MELLITUS; DIABETIC NEUROPATHY; DISEASE DURATION; FEMALE; HUMAN; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; NERVE FUNCTION; PRIORITY JOURNAL; RISK FACTOR; SENSORY NERVE; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 0030047795     PISSN: 10568727     EISSN: None     Source Type: Journal    
DOI: 10.1016/1056-8727(94)00055-7     Document Type: Article

References (24)

1. Vinik AI, Holland MT, Le Beau JM, Liuzzi FJ, Stansberry KB, Colen LB: Diabetic neuropathies. Diabetes Care 15:1926-1975, 1992.
2. Harris M, Eastman R, Cowie C: Symptoms of sensory neuropathy in adults with NIDDM in the U.S. population. Diabetes Care 16:1446-1452, 1993.
3. Consensus Statement. Report and recommendations of the San Antonio conference on diabetic neuropathy. Diabetes 37:1000-1004, 1988.
4. Maser RE, Steenkiste AR, Dorman JS, Nielsen VK, Bass EB, Manjoo Q, Drash AL, Becker DJ, Kuller LH, Greene DA, Orchard TJ: Epidemiological correlates of diabetic neuropathy. Report from Pittsburgh Epidemiology of Diabetes Complications Study. Diabetes 38:1456-1461, 1989.
5. Bergenheim T, Borssen B, Lithner F: Sensory thresholds for vibration, perception and pain in diabetic patients aged 15-50 years. Diabetes Res Clin Pract 16:47-52, 1992.
6. Maser RE, Nielsen VK, Dorman JS, Drash AL, Becker DJ, Orchard TJ: Measuring subclinical neuropathy: Does it relate to clinical neuropathy? Pittsburgh Epidemiology of Diabetes Complications Study-V. J Diabet Complications 5:6-12, 1991.
7. Mitchell BD, Hawthorne VM, Vinik AI: Cigarette smoking and neuropathy in diabetic patients. Diabetes Care 13:434-437, 1990.
8. Sosenko JM, Gadia MT, Fournier AM, O'Connell MT, Aguiar MC, Skyler JS: Body stature as a risk factor for diabetic sensory neuropathy. Am J Med 80:1031-1034, 1986.
9. Rhoads GG, Dahlen G, Berg K, Morton NE, Dannenberg AL: Lp(a) lipoprotein as a risk factor for myocardial infarction. JAMA 256:2540-2544, 1986.
10. Dahlen GH, Guyton JR, Attar M, Farmer JA, Kautz JA, Gotto AM: Association of levels of lipoprotein Lp(a), plasma lipids, and other lipoproteins with coronary artery disease documented by angiography. Circulation 74:758-765, 1986.
11. Zenker G, Koltringer P, Bone G, Niederkorn K, Pfeiffer K, Jurgens G: Lipoprotein (a) as a strong indicator for cerebrovascular disease. Stroke 17:942-945, 1986.
12. Jurgens G, Koltringer P: Lipoprotein (a) in ischemic cerebrovascular disease: a new approach to the assessment of risk for stroke. Neurology 37:513-515, 1987.
13. Wolffenbuttel BHR, Leurs PB, Sels JPJE, Rondas-Colbers GJWM, Menheere PPCA, Nieuwenhuijzen Kruseman AC: Improved blood glucose control by insulin therapy in type 2 diabetic patients has no effect on lipoprotein(a) levels. Diabetic Med 10:427-430, 1993.
14. Couper JJ, Bates DJ, Cocciolone R, Magarey AM, Boulton TJC, Penfold JL, Ryall RG: Association of lipoprotein(a) with puberty in IDDM. Diabetes Care 16:869-873, 1993.
15. Miles LA, Plow EF: Lp(a): an interloper into the fibrinolytic system? Thromb Haemost 63:331-335, 1990.
16. Scanu AM: Lipoprotein(a) as a cardiovascular risk factor. Trends Cardiovasc Med 1:294-299, 1991.
17. Kapelrud H, Bangstad HJ, Dahl-Jorgensen K, Berg K, Hanssen KF: Serum Lp(a) lipoprotein concentrations in insulin-dependent diabetic patients with microalbuminuria. BMJ 303:675-678, 1991.
18. Jenkins AJ, Steele JS, Janus ED, Best JD: Increased plasma apolipoprotein (a) levels in IDDM patients with microalbuminuria. Diabetes 40:787-790, 1991.
19. Haffner SM, Moss SE Klein BEK, Klein R: Lack of association between lipoprotein (a) concentrations and coronary heart disease mortality in diabetes: the Wisconsin Epidemiologic Study of Diabetic Retinopathy. Metabolism 41:194-197, 1992.
20. Maser RE, Usher D, Becker DJ, Drash AL, Kuller LH, Orchard TJ: Lipoprotein(a) concentration shows little relationship to IDDM complications in the Pittsburgh Epidemiology of Diabetes Complications Study Cohort. Diabetes Care 16:755-758, 1993.
21. Maser RE, Nielsen VK, Bass EB, Manjoo Q, Dorman JS, Kelsey SF, Becker DJ, Orchard TJ: Measuring diabetic neuropathy. Assessment and comparison of clinical examination and quantitative sensory testing. Diabetes Care 12:270-275, 1989.
22. Maser RE, Laudadio C, DeCherney GS: The effects of age and diabetes mellitus on nerve function. J Am Geriatr Soc 41:1202-1204, 1993.
23. Bray GA: Overweight is risking fate: definition, classification, prevalence and risks. Ann NY Acad Sci 499:14-28, 1987.
24. Gadia MT, Natori N, Ramos LB, Ayyar DR, Skyler JS, Sosenko JM: Influence of height on quantitative sensory, nerve-conduction, and clinical indices of diabetic peripheral neuropathy. Diabetes Care 10:613-616, 1987.